Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Investigational Allergology & Clinical Immunology|September 18, 2018
Therapeutic Strategy According to Differences in Response to Omalizumab in Patients With Chronic Spontaneous UrticariaA M Giménez Arnau, A Valero Santiago, J Bartra Tomás, et al.Actas Dermo-Sifiliograficas|December 14, 2025
Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From SpainJ F Silvestre-Salvador, S Santos-Alarcón, A Mengual-Sendra, et al.Actas Dermo-Sifiliograficas|May 14, 2020
Quality Indicators in Care of Patients With Atopic Dermatitis: Consensus Document of the Spanish Academy of Dermatology and VenereologyI Poveda-Montoyo, I García-Doval, M A Descalzo, et al.Actas Dermo-Sifiliograficas|May 8, 2022
Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)V Mora-Fernández, P Mercader Garcia, L Borrego Hernando, et al.Contact Dermatitis|August 14, 2024
Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)P Chicharro, M Munera-Campos, V Zaragoza-Ninet, et al.Actas Dermo-Sifiliograficas|October 11, 2025
[Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.Actas Dermo-Sifiliograficas|March 2, 2025
Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.Pageof 1